NASDAQ:ISRG - Nasdaq - US46120E6023 - Common Stock - Currency: USD
482.74
+1.4 (+0.29%)
The current stock price of ISRG is 482.74 USD. In the past month the price decreased by -1.84%. In the past year, price increased by 31.77%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABT | ABBOTT LABORATORIES | 27.4 | 227.16B | ||
BSX | BOSTON SCIENTIFIC CORP | 37.9 | 140.69B | ||
SYK | STRYKER CORP | 28.42 | 132.26B | ||
MDT | MEDTRONIC PLC | 15.47 | 105.94B | ||
BDX | BECTON DICKINSON AND CO | 14.29 | 57.06B | ||
EW | EDWARDS LIFESCIENCES CORP | 27.3 | 42.05B | ||
IDXX | IDEXX LABORATORIES INC | 36.58 | 33.35B | ||
RMD | RESMED INC | 24.08 | 31.27B | ||
GEHC | GE HEALTHCARE TECHNOLOGY | 13.89 | 28.52B | ||
DXCM | DEXCOM INC | 41.56 | 26.89B | ||
PHG | KONINKLIJKE PHILIPS NVR- NY | 15.04 | 22.19B | ||
STE | STERIS PLC | 24.21 | 21.83B |
Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. The company is headquartered in Sunnyvale, California and currently employs 15,638 full-time employees. The company went IPO on 2000-06-13. The firm specializes in invasive care and robotic-assisted surgery. Its technologies include the da Vinci surgical systems and the Ion endoluminal system. The da Vinci surgical system is designed to enable surgeons to perform a range of surgical procedures within its targeted general surgery, urologic, gynecologic, cardiothoracic, and head and neck specialties and consists of a surgeon's console or consoles, a patient-side cart, and a high-performance vision system. The Ion endoluminal system is a flexible, robotic-assisted, catheter-based platform for which the cleared indication is minimally invasive biopsies in the lung and consists of a system cart, a controller, a catheter, and a vision probe. Its Ion system extends its commercial offering beyond surgery into diagnostic and endoluminal procedures.
INTUITIVE SURGICAL INC
1020 Kifer Road
Sunnyvale CALIFORNIA 94086 US
CEO: Gary S. Guthart
Employees: 13676
Company Website: https://www.intuitive.com/en-us/about-us/company
Investor Relations: https://isrg.intuitive.com
Phone: 14085232100
The current stock price of ISRG is 482.74 USD. The price increased by 0.29% in the last trading session.
The exchange symbol of INTUITIVE SURGICAL INC is ISRG and it is listed on the Nasdaq exchange.
ISRG stock is listed on the Nasdaq exchange.
39 analysts have analysed ISRG and the average price target is 644.51 USD. This implies a price increase of 33.51% is expected in the next year compared to the current price of 482.74. Check the INTUITIVE SURGICAL INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
INTUITIVE SURGICAL INC (ISRG) has a market capitalization of 172.95B USD. This makes ISRG a Large Cap stock.
INTUITIVE SURGICAL INC (ISRG) currently has 13676 employees.
INTUITIVE SURGICAL INC (ISRG) has a support level at 453.36 and a resistance level at 492.22. Check the full technical report for a detailed analysis of ISRG support and resistance levels.
The Revenue of INTUITIVE SURGICAL INC (ISRG) is expected to grow by 17.28% in the next year. Check the estimates tab for more information on the ISRG EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
ISRG does not pay a dividend.
INTUITIVE SURGICAL INC (ISRG) will report earnings on 2025-04-22, after the market close.
The PE ratio for INTUITIVE SURGICAL INC (ISRG) is 65.86. This is based on the reported non-GAAP earnings per share of 7.33 and the current share price of 482.74 USD. Check the full fundamental report for a full analysis of the valuation metrics for ISRG.
The outstanding short interest for INTUITIVE SURGICAL INC (ISRG) is 1.36% of its float. Check the ownership tab for more information on the ISRG short interest.
ChartMill assigns a technical rating of 3 / 10 to ISRG. When comparing the yearly performance of all stocks, ISRG is one of the better performing stocks in the market, outperforming 82.73% of all stocks.
ChartMill assigns a fundamental rating of 6 / 10 to ISRG. ISRG has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company.
Over the last trailing twelve months ISRG reported a non-GAAP Earnings per Share(EPS) of 7.33. The EPS increased by 28.37% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 27.81% | ||
ROA | 12.39% | ||
ROE | 14.05% | ||
Debt/Equity | 0 |
ChartMill assigns a Buy % Consensus number of 79% to ISRG. The Buy consensus is the average rating of analysts ratings from 39 analysts.
For the next year, analysts expect an EPS growth of 11.93% and a revenue growth 17.28% for ISRG